Clincosm LogoSign in Get a demo

Hypertension,Essential

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

Not yet recruiting
  • Hypertension,Essential
  • Songling Xuemaikang Capsules
  • +2 more
  • Beijing, Beijing, China
  • +4 more
Oct 17, 2023

Hypertension,Essential Trial in Seoul (AD-223A, AD-223B, AD-223C)

Not yet recruiting
  • Hypertension,Essential
  • Seoul, Korea, Republic of
    Hanyang University Hospital
Sep 19, 2023

Hypertension, Hypertension,Essential Trial (TENS - Cervical stimulation group, TENS - Plus cervical stimulation group, TENS -

Not yet recruiting
  • Hypertension
  • Hypertension,Essential
  • TENS - Cervical stimulation group
  • +2 more
  • (no location specified)
Sep 8, 2023

Hypertension,Essential Trial in Norrköping (Licorice)

Not yet recruiting
  • Hypertension,Essential
  • Licorice
  • Norrköping, Östergötland, Sweden
    Cityhälsan Centrum
Aug 25, 2023

Long-term Use of CCB and Breast Cancer Risk

Active, not recruiting
  • Hypertension,Essential
  • Breast Cancer
  • Calcium channel blocker
  • +5 more
  • Bentley, Western Australia, Australia
    Curtin university
Aug 1, 2023

Hypertension,Essential Trial (Sweet licorice, Salty licorice)

Not yet recruiting
  • Hypertension,Essential
  • Sweet licorice
  • Salty licorice
  • (no location specified)
Dec 21, 2022

Anxiety Disorders and Symptoms, Fibromyalgia, Arthritis Trial in Dover (IV Vitamin Infused Therapy Treatment, Herbal medicine)

Recruiting
  • Anxiety Disorders and Symptoms
  • +4 more
  • IV Vitamin Infused Therapy Treatment
  • Herbal medicine
  • Dover, Delaware
    The Essence of Integrative Health and Medicine Practice
Nov 17, 2022

Hypertension,Essential, Systolic Hypertension Trial in Czechia, Hungary, Poland (Programmable Hypertension Control (BackBeat

Recruiting
  • Hypertension,Essential
  • Systolic Hypertension
  • Programmable Hypertension Control (BackBeat Moderato)
  • Pacing (BackBeat Moderato)
  • Praha, Czechia
  • +5 more
Nov 2, 2022

Hypertension,Essential Trial in Copenhagen (Training)

Completed
  • Hypertension,Essential
  • Training
  • Copenhagen, Denmark
    University of Copenhagen
Nov 1, 2022

Hypertension,Essential, Adherence, Medication, Quality of Life Trial in Pittsburgh (Coaching application, WebMD, Home-based

Not yet recruiting
  • Hypertension,Essential
  • +2 more
  • Coaching application
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Sep 19, 2022

Pharmacological and Nonpharmacological Factors That Contribute

Completed
  • Hypertension,Essential
    • (no location specified)
    Aug 23, 2022

    Diabetic Retinopathy, Retinal Vein Occlusion, Hypertension,Essential Trial in Baltimore (Swept-Source OCT Angiography,

    Recruiting
    • Diabetic Retinopathy
    • +3 more
    • Swept-Source OCT Angiography
    • +3 more
    • Baltimore, Maryland
      Wilmer Eye Institute
    Aug 10, 2022

    Effectiveness and Safety of Amosartan Plus Tablet

    Completed
    • Hypertension,Essential
    • Amosartan Plus Tab.
    • Seoul, Korea, Republic of
      Hanmi Pharmaceutical Company Limited
    Jul 14, 2022

    Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

    Recruiting
    • Hypertension,Essential
      • Seoul, Korea, Republic of
        Seoul National University Bundang Hospital
      Jul 7, 2022

      Hypertension, Hypertension,Essential Trial in Worldwide (Alcohol, Sham control)

      Active, not recruiting
      • Hypertension
      • Hypertension,Essential
      • Brussels, Belgium
      • +3 more
      Jun 8, 2022

      Hypertension,Essential, Hypertension, Blood Pressure Disorders Trial in Maia (Recreational Futsal)

      Active, not recruiting
      • Hypertension,Essential
      • +3 more
      • Recreational Futsal
      • Maia, Portugal
        University of Maia
      May 20, 2022

      Hypertension,Essential Trial in Herning (Sodium restriction)

      Recruiting
      • Hypertension,Essential
      • Sodium restriction
      • Herning, Denmark
        University Clinic in Nephrology and Hypertension
      Mar 17, 2022

      Hypertension,Essential, White Coat Hypertension Trial in New York (Multifaceted Implementation Strategy)

      Active, not recruiting
      • Hypertension,Essential
      • White Coat Hypertension
      • Multifaceted Implementation Strategy
      • New York, New York
        Center for Behavioral Cardiovascular Health
      Mar 7, 2022

      Hypertension, Hypertension,Essential Trial (fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg, Isolated drugs Olmesartan

      Not yet recruiting
      • Hypertension
      • Hypertension,Essential
      • fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg
      • Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg)
      • (no location specified)
      Mar 17, 2022

      Hypertension,Essential, Hypertension, Uncontrolled Trial in Mendoza, Shanghai (Usual care, POST-strategy)

      Recruiting
      • Hypertension,Essential
      • Hypertension, Uncontrolled
      • Usual care
      • POST-strategy
      • Mendoza, Argentina
      • +1 more
      Mar 1, 2022

      Hypertension,Essential Trial in University Park (Captopril Pill, Enalapril Pill, Hydrochlorothiazide)

      Enrolling by invitation
      • Hypertension,Essential
      • Captopril Pill
      • +2 more
      • University Park, Pennsylvania
        Pennsylvania State University
      Feb 16, 2022

      Hypertension,Essential, Prehypertension Trial in Beijing (Remote ischemic conditioning (RIC), Sham remote ischemic conditioning

      Recruiting
      • Hypertension,Essential
      • Prehypertension
      • Remote ischemic conditioning (RIC)
      • Sham remote ischemic conditioning (Sham-RIC)
      • Beijing, Beijing, China
      • +2 more
      Dec 5, 2021

      Hypertension,Essential Trial in China (SPH3127 tablet Dose 1, SPH3127 tablet Dose 2, SPH3127 tablet Dose 3)

      Completed
      • Hypertension,Essential
      • SPH3127 tablet Dose 1
      • +3 more
      • Beijing, China
      • +9 more
      Nov 11, 2021

      Renoprotective Effect of Fimasartan in DKD and Proteinuria

      Recruiting
      • Diabetic Kidney Disease
      • +2 more
        • Seoul, Korea, Republic of
          Severance hospital, Yonsei University Health System
        Oct 7, 2021

        Hypertension,Essential Trial in Shenzhen, Kowloon (Educational program for hypertensive patients, Usual care)

        Recruiting
        • Hypertension,Essential
        • Educational program for hypertensive patients
        • Usual care
        • Shenzhen, Shenzhen, China
        • +1 more
        Aug 2, 2021